NEW YORK, March 28, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Caterpillar Inc. (“Caterpillar” or the “Company”) (NYSE:CAT) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Caterpillar securities between February 19, 2013 and March 1, 2017, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/cat.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Caterpillar unlawfully used foreign subsidiaries to avoid paying billions of dollars in U.S. taxes; (2) discovery of the foregoing conduct would subject the Company to heightened regulatory scrutiny and potential criminal sanctions; and (3) consequently, Caterpillar’s public statements were materially false and misleading at all relevant times.
On March 2, 2017, law enforcement officials executing a search warrant searched Caterpillar’s facilities in Peoria, Illinois. The Peoria Journal Star narrated that some of the officials wearing Internal Revenue Service logo jackets were seen entering the company’s headquarters. Following this news, Caterpillar stock has dropped $4.22 per share, or 4.28%, to close at $94.36 per share on March 2, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/cat or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Caterpillar you have until May 2, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Meta Expands AI Training With Employee Activity Tracking Tools
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 



